Cost-Utility Analysis of Intramuscular Interferon Beta-1b Versus Subcutaneous Interferon Beta-1b and Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in Colombia

May 1, 2016, 00:00
10.1016/j.jval.2016.03.204
https://www.valueinhealthjournal.com/article/S1098-3015(16)00272-2/fulltext
Title : Cost-Utility Analysis of Intramuscular Interferon Beta-1b Versus Subcutaneous Interferon Beta-1b and Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in Colombia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00272-2&doi=10.1016/j.jval.2016.03.204
First page : A63
Section Title : Neurological Disorders - Cost Studies
Open access? : No
Section Order : 1539
Categories :
Tags :
Regions :
ViH Article Tags :